Daisuke Kashiwakuma
Chiba University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daisuke Kashiwakuma.
Journal of Experimental Medicine | 2008
Akira Suto; Daisuke Kashiwakuma; Shin-ichiro Kagami; Koichi Hirose; Norihiko Watanabe; Kotaro Yokote; Yasushi Saito; Toshinori Nakayama; Michael J. Grusby; Itsuo Iwamoto; Hiroshi Nakajima
It has recently been shown that interleukin (IL)-21 is produced by Th17 cells, functions as an autocrine growth factor for Th17 cells, and plays critical roles in autoimmune diseases. In this study, we investigated the differentiation and characteristics of IL-21–producing CD4+ T cells by intracellular staining. Unexpectedly, we found that under Th17-polarizing conditions, the majority of IL-21–producing CD4+ T cells did not produce IL-17A and -17F. We also found that IL-6 and -21 potently induced the development of IL-21–producing CD4+ T cells without the induction of IL-4, IFN-γ, IL-17A, or IL-17F production. On the other hand, TGF-β inhibited IL-6– and IL-21–induced development of IL-21–producing CD4+ T cells. IL-2 enhanced the development of IL-21–producing CD4+ T cells under Th17-polarizing conditions. Finally, IL-21–producing CD4+ T cells exhibited a stable phenotype of IL-21 production in the presence of IL-6, but retained the potential to produce IL-4 under Th2-polarizing conditions and IL-17A under Th17-polarizing conditions. These results suggest that IL-21–producing CD4+ T cells exhibit distinct characteristics from Th17 cells and develop preferentially in an IL-6–rich environment devoid of TGF-β, and that IL-21 functions as an autocrine growth factor for IL-21–producing CD4+ T cells.
Journal of Leukocyte Biology | 2010
Yukiko Hiramatsu; Akira Suto; Daisuke Kashiwakuma; Hiroko Kanari; Shin-ichiro Kagami; Kei Ikeda; Koichi Hirose; Norihiko Watanabe; Michael J. Grusby; Itsuo Iwamoto; Hiroshi Nakajima
Previous studies have shown that IL‐6 potently induces IL‐21 production in CD4+ T cells, whereas TGF‐β inhibits IL‐6‐induced IL‐21 production in CD4+ T cells. In this study, we addressed the mechanisms underlying the transcriptional regulation of IL‐21 production in CD4+ T cells. We found that IL‐6 induced c‐Maf expression in CD4+ T cells and that the enforced expression of c‐Maf induced IL‐21 production in CD4+ T cells without IL‐6, IL‐4/STAT6 signaling, or an autocrine effect of IL‐21. Moreover, we found that c‐Maf directly bound to and activated IL‐21P and the CNS‐2 enhancer through MARE sites. On the other hand, we also found that although TGF‐β up‐regulated IL‐6‐induced c‐Maf expression in CD4+ T cells, TGF‐β inhibited c‐Maf‐induced IL‐21 production in CD4+ T cells. Finally, we found that Foxp3 bound to IL‐21P and the CNS‐2 enhancer and inhibited c‐Maf‐induced IL‐21 production modestly but significantly in CD4+ T cells. Taken together, these results suggest that c‐Maf induces IL‐21 production directly in CD4+ T cells by activating IL‐21P and the CNS‐2 enhancer and that TGF‐β suppresses c‐Maf‐induced IL‐21 production in CD4+ T cells.
International Archives of Allergy and Immunology | 2010
Hiroko Kanari; Shin-ichiro Kagami; Daisuke Kashiwakuma; Yoshihiro Oya; Shunsuke Furuta; Kei Ikeda; Akira Suto; Kotaro Suzuki; Koichi Hirose; Norihiko Watanabe; Yoshitaka Okamoto; Shuichi Yamamoto; Itsuo Iwamoto; Hiroshi Nakajima
Background: Lacrimal gland enlargement (LGE) is one of the characteristics of Mikulicz’s disease (MD). Recently, marked serum IgG4 elevation and infiltration of IgG4-positive plasmacytes in the enlarged exocrine glands have been reported in MD patients. However, little is known about the role of CD4+ T cells and their cytokines in IgG4-related diseases. The aim of this study was to evaluate the characteristics of CD4+ T cells in patients with IgG4-related diseases. Methods: We investigated the clinical characteristics of 9 patients with LGE and elevated serum IgG4 levels (named IgG4-related LGE). We also examined mRNA expression of cytokines and transcription factors of peripheral blood CD4+ T cells in patients with IgG4-related LGE. Results: All patients with IgG4-related LGE showed elevated serum IgE levels. In addition, 5 of 9 patients with IgG4-related LGE exhibited eosinophilia and asthma-like symptoms. In patients with IgG4-related LGE, mRNA expression of IL-4, IL-5, IL-10 and GATA-3 but not IFN-γ or T-bet was enhanced on CD4+ T cells compared with that in healthy controls. Conclusions: Th2 cells may be involved in the pathogenesis of IgG4-related diseases.
Arthritis & Rheumatism | 2014
Yoshie Sanayama; Kei Ikeda; Yukari Saito; Shin-ichiro Kagami; Mieko Yamagata; Shunsuke Furuta; Daisuke Kashiwakuma; Itsuo Iwamoto; Takeshi Umibe; Yasushi Nawata; Ryutaro Matsumura; Takao Sugiyama; Makoto Sueishi; Masaki Hiraguri; Ken Nonaka; Osamu Ohara; Hiroshi Nakajima
The aim of this prospective multicenter study was to identify biomarkers that can be used to predict therapeutic responses to tocilizumab in patients with rheumatoid arthritis (RA).
Journal of Experimental Medicine | 2014
Shigeru Tanaka; Akira Suto; Taro Iwamoto; Daisuke Kashiwakuma; Shin-ichiro Kagami; Kotaro Suzuki; Hiroaki Takatori; Tomohiro Tamachi; Koichi Hirose; Atsushi Onodera; Junpei Suzuki; Osamu Ohara; Masakatsu Yamashita; Toshinori Nakayama; Hiroshi Nakajima
A novel isoform of Sox5, Sox5t, and c-Maf activate RORγt to induce Th17 cells. Sox5−/− mice exhibit impaired Th17 differentiation and are thus resistant to EAE and delayed-type hypersensitivity.
Journal of Immunology | 2010
Daisuke Kashiwakuma; Akira Suto; Yukiko Hiramatsu; Kei Ikeda; Hiroaki Takatori; Kotaro Suzuki; Shin-ichiro Kagami; Koichi Hirose; Norihiko Watanabe; Itsuo Iwamoto; Hiroshi Nakajima
We recently showed that mice lacking B and T lymphocyte attenuator (BTLA), a third inhibitory coreceptor expressed on B cells and T cells, exhibit an increased Ag-specific IgG response and gradually develop hyper-γ–globulinemia and autoantibody production. Recent studies revealed that follicular Th (Tfh) cells, which are non-Th1, non-Th2 effector T cells that express CXCR5 and provide help for B cells to produce Ig, also express BTLA. However, the role of BTLA in Tfh cell function remains unknown. In this study, we examined the regulatory role of BTLA in the development and function of Tfh cells. We found that CXCR5+ Tfh cells expressed higher levels of BTLA than did CXCR5− conventional CD4+ T cells. We also found that adoptive transfer of BTLA−/− CD4+ T cells, stimulated under Tfh cell-inducing conditions (Tfh-like cells), to wild-type (WT) mice induced more Ag-specific IgG2a and IgG2b production compared with that of WT Tfh-like cells. By contrast, another adoptive-transfer experiment using BTLA−/− mice as recipients showed that the expression of BTLA on B cells was not involved in the regulation of Tfh-like cell-mediated Ag-specific IgG responses. Moreover, the development of IL-21–producing CXCR5+ Tfh-like cells was significantly increased in BTLA−/− CD4+ T cells compared with WT CD4+ T cells. Furthermore, Tfh-like cell-mediated IgG responses were abolished when IL-21R−/− mice were used as recipients. These results suggest that BTLA signaling suppresses IL-21 production from Tfh cells and subsequent Tfh cell-mediated IgG responses.
The Journal of Rheumatology | 2014
Shunsuke Furuta; Afzal N. Chaudhry; Yoshitomo Hamano; Shouichi Fujimoto; Hiroko Nagafuchi; Hirofumi Makino; Seiichi Matsuo; Shoichi Ozaki; Tomomi Endo; Eri Muso; Chiharu Ito; Eiji Kusano; Mieko Yamagata; Kei Ikeda; Daisuke Kashiwakuma; Itsuo Iwamoto; Kerstin Westman; David Jayne
Objective. There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan. Methods. Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis. Results. The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p < 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors. Conclusion. Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar.
Arthritis & Rheumatism | 2014
Yukari Saito; Shin-ichiro Kagami; Yoshie Sanayama; Kei Ikeda; Akira Suto; Daisuke Kashiwakuma; Shunsuke Furuta; Itsuo Iwamoto; Ken Nonaka; Osamu Ohara; Hiroshi Nakajima
The proinflammatory cytokines tumor necrosis factor α and interleukin‐6 (IL‐6) and the Th17 cell cytokine IL‐17A are implicated in the pathogenesis of rheumatoid arthritis (RA), and the blockade of these cytokines by biologic agents provides clinical benefits for RA patients. We undertook this study to clarify the mechanisms underlying the efficacy of IL‐6 blockade in RA and to find a novel target for treatment of RA.
Arthritis & Rheumatism | 2016
Mieko Yamagata; Kei Ikeda; Kenji Tsushima; Ken Iesato; Mitsuhiro Abe; Takashi Ito; Daisuke Kashiwakuma; Shin-ichiro Kagami; Itsuo Iwamoto; Daiki Nakagomi; Takao Sugiyama; Yuichiro Maruyama; Shunsuke Furuta; David Jayne; Takashi Uno; Koichiro Tatsumi; Hiroshi Nakajima
To determine the prevalence of lung abnormalities on chest computed tomography (CT) in patients with microscopic polyangiitis (MPA), to assess the responsiveness of such abnormalities to initial treatment, and to assess associations between these abnormalities and patient and disease characteristics and mortality.
Arthritis & Rheumatism | 2015
Mieko Yamagata; Kei Ikeda; Kenji Tsushima; Ken Iesato; Mitsuhiro Abe; Takashi Ito; Daisuke Kashiwakuma; Shin-ichiro Kagami; Itsuo Iwamoto; Daiki Nakagomi; Takao Sugiyama; Yuichiro Maruyama; Shunsuke Furuta; David Jayne; Takashi Uno; Koichiro Tatsumi; Hiroshi Nakajima
To determine the prevalence of lung abnormalities on chest computed tomography (CT) in patients with microscopic polyangiitis (MPA), to assess the responsiveness of such abnormalities to initial treatment, and to assess associations between these abnormalities and patient and disease characteristics and mortality.